Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2010

View Archived Issues

AGN-203818 useful to reduce hypersensitivity in heartburn and IBS patients

Acute rejection rates similar with CP-690550 and ciclosporin in renal transplant patients

Pfizer identifies new fatty-acid amide hydrolase inhibitors

Ranolazine exhibits antifibrillatory activity during severe coronary stenosis

Phase II data in cystic fibrosis disclosed on TR-02

Clinical safety and pharmacokinetic data of inhaled liposomal ciprofloxacin reported

Comparable safety/efficacy/tolerability of ilaprazole and esomeprazole in duodenal ulcer

Increased IGFBP-7 expression reduces breast cancer growth

Lundbeck reports highlights of first quarter 2010

NeuroTherapeutics closes series B financing to advance pipeline

Vagifem 10-mcg tablets replace 25-mcg formulation for atrophic vaginitis

Anadys reports on phase II combination trial of ANA-598

AndroScience and Orient Europharma collaborate on topical acne therapy

Bayer Schering Pharma claims new MEK 1 inhibitors

Janssen describes new serotonin receptor ligands

Ligand acquires milestone and royalty interest in MEDI-528 for asthma

New mGlu5 receptor antagonists claimed by GlaxoSmithKline

Sorrento Therapeutics receives NIH grant for innovative MRSA infection program

Grifols acquires Pharmalink's post-polio syndrome drug development project

NORD awards Shire for developing VPRIV in Gaucher's disease

Elagolix meets all efficacy endpoints in phase II trial in endometriosis

FDA extends review period of FTY-720 in relapsing MS

New data on coadministration of Intuniv and stimulants in ADHD

Enrollment complete in phase II brentuximab vedotin trial in ALCL

Phase III data reported on clobazam in Lennox-Gastaut syndrome

Intercell honored for developing IC-51 Japanese encephalitis vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.